Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Shipman, Claire M."'
Autor:
Shipman, Claire M.1, Rogers, Michael J.2, Vanderkerken, Karin3, Van Camp, Ben3, Russell, R. Graham G.1, Croucher, Peter I.1
Publikováno v:
Acta Oncologica. 2000, Vol. 39 Issue 7, p829-835. 7p. 3 Diagrams, 1 Chart, 2 Graphs.
Autor:
Shipman, Claire M., Rogers, Michael J., Apperley, Jane F., Russell, R. Graham G., Croucher, Peter I.
Publikováno v:
Leukemia & Lymphoma. Dec98, Vol. 32 Issue 1/2, p129. 10p. 2 Black and White Photographs, 2 Diagrams, 3 Charts.
Autor:
Karin Vanderkerken, Leenheer, E., Shipman, Claire M., Kewal Asosingh, Angelo Willems, Benjamin Van Camp, Croucher, Peter I.
Publikováno v:
Scopus-Elsevier
ResearcherID
Europe PubMed Central
Vrije Universiteit Brussel
ResearcherID
Europe PubMed Central
Vrije Universiteit Brussel
The aim of the present study was to determine whether modifying the local bone environment with osteoprotegerin (OPG), the soluble decoy receptor for receptor activator of nuclear factor-kappaB (RANK) ligand, could affect tumor burden and survival in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::030113026fa007979a22f52993dde3df
https://biblio.vub.ac.be/vubir/recombinant-osteoprotegerin-decreases-tumor-burden-and-increases-survival-in-a-murine-model-of-multiple-myeloma(f6f8a6da-a971-485f-80dc-d45fc7d32a32).html
https://biblio.vub.ac.be/vubir/recombinant-osteoprotegerin-decreases-tumor-burden-and-increases-survival-in-a-murine-model-of-multiple-myeloma(f6f8a6da-a971-485f-80dc-d45fc7d32a32).html
Publikováno v:
Vrije Universiteit Brussel
BACKGROUND: A major clinical feature in multiple myeloma is the development of osteolytic bone disease. The increase in bone destruction is due to uncontrolled osteoclastic bone resorption. Until recently the factors responsible for mediating the inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::66ebd47c500d16517b4fa4884828cb5c
https://biblio.vub.ac.be/vubir/biphosphonates-and-osteoprotegerin-as-inhibitors-of-myeloma-bone-disease(fc3dacfd-f28d-4046-9754-89bf6a3486ab).html
https://biblio.vub.ac.be/vubir/biphosphonates-and-osteoprotegerin-as-inhibitors-of-myeloma-bone-disease(fc3dacfd-f28d-4046-9754-89bf6a3486ab).html
Autor:
Shipman, Claire M., Mueller, Gabrielle, Vanderkerken, Karin, Perry, M., Cordiner-Lawrie, Sandy, Russell, Graham G., Van Camp, Benjamin, Niesor, Eric, Bentzen, Craig L., Croucher, Peter I.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3848::8ada4f384f6a800a24f56d2db5d38d15
https://biblio.vub.ac.be/vubir/apomine-a-novel-inhibitor-of-the-mevalonateisoprenoid-pathway-promotes-apoptosis-of-myeloma-cells-in-vitro-and-is-associated-with-a-modulation-of-myeloma-disease-in-vivo(8f8a6213-6903-47d5-9fd5-50184f05baf7).html
https://biblio.vub.ac.be/vubir/apomine-a-novel-inhibitor-of-the-mevalonateisoprenoid-pathway-promotes-apoptosis-of-myeloma-cells-in-vitro-and-is-associated-with-a-modulation-of-myeloma-disease-in-vivo(8f8a6213-6903-47d5-9fd5-50184f05baf7).html
Autor:
De Leenheer, Evy, Vanderkerken, Karin, Mueller, Gabrielle, Shipman, Claire M., Bakkus, Marleen, Van Camp, Benjamin, Croucher, Peter I.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3848::652903f08ca533633524475e0470a5cd
https://biblio.vub.ac.be/vubir/evidence-for-a-role-for-bone-marrow-endothelial-cells-in-the-development-of-myeloma-bone-disease(f87c7098-224a-4688-a812-9c3eb359825a).html
https://biblio.vub.ac.be/vubir/evidence-for-a-role-for-bone-marrow-endothelial-cells-in-the-development-of-myeloma-bone-disease(f87c7098-224a-4688-a812-9c3eb359825a).html
Autor:
De Leenheer, Evy, Vanderkerken, Karin, Bakkus, Marleen, Van Camp, Benjamin, Shipman, Claire M., Croucher, Peter I.
Publikováno v:
BLOOD. 100(11)
Autor:
Croucher, Peter I., Shipman, Claire M., Lippitt, J., Perry, M., Kewal Asosingh, Brabbs, A. C., Beek, E. J. R., Holen, I., Skerry, T. M., Dunstan, C. R., Russell, Graham G., Benjamin Van Camp, Karin Vanderkerken
Publikováno v:
Vrije Universiteit Brussel
Multiple myeloma is a B-cell malignancy characterized by the accumulation of plasma cells in the bone marrow and the development of osteolytic bone disease. The present study demonstrates that myeloma cells express the critical osteoclastogenic facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2052bcf6c6b317f416faf68f94117c18
https://biblio.vub.ac.be/vubir/osteoprotegerin-inhibits-the-development-of-osteolytic-bone-disease-in-multiple-myeloma(ef9263b7-0711-405f-9611-a64f08de15ff).html
https://biblio.vub.ac.be/vubir/osteoprotegerin-inhibits-the-development-of-osteolytic-bone-disease-in-multiple-myeloma(ef9263b7-0711-405f-9611-a64f08de15ff).html
Autor:
Croucher, Peter I., Shipman, Claire M., Perry, M., Lippitt, J., Asosingh, Kewal, Van Beek, E., Van Camp, Benjamin, Russell, Graham G., Dunstan, C., Vanderkerken, Karin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3848::d8b57208c57fd1c1fa039d62ed1cff58
https://biblio.vub.ac.be/vubir/osteoprotegerin-opg-inhibits-the-development-of-osteolytic-bone-disease-in-the-5t2-mm-model-of-multiple-myeloma(b4fd558a-a379-4870-9467-9cea6d5520c2).html
https://biblio.vub.ac.be/vubir/osteoprotegerin-opg-inhibits-the-development-of-osteolytic-bone-disease-in-the-5t2-mm-model-of-multiple-myeloma(b4fd558a-a379-4870-9467-9cea6d5520c2).html
Autor:
Shipman, Claire M., Karin Vanderkerken, Michael Rogers, Lippitt, J., Kewal Asosingh, Hargreaves, P. G., Hughes, D. E., Benjamin Van Camp, Russell, R. G., Croucher, Peter I.
Publikováno v:
Vrije Universiteit Brussel
Bisphosphonates are effective in the management of bone disease in patients with multiple myeloma and recent reports have suggested that they may also have an anti-tumour activity. In support of this, we have previously demonstrated that bisphosphona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::34cdd690a3ca7fd570e97636689614c2
https://biblio.vub.ac.be/vubir/the-potent-bisphosphonate-ibandronate-does-not-induce-myeloma-cell-apoptosis-in-a-murine-model-of-established-multiple-myeloma(d5bd532e-70b0-49ee-8d8e-c6bd30bb3328).html
https://biblio.vub.ac.be/vubir/the-potent-bisphosphonate-ibandronate-does-not-induce-myeloma-cell-apoptosis-in-a-murine-model-of-established-multiple-myeloma(d5bd532e-70b0-49ee-8d8e-c6bd30bb3328).html